JPST Editorial Board

Acting Editor-in-Chief

Shanker Gupta, PhD

Dr. Shanker Gupta has stepped up to take on the role of Acting Editor-in-Chief while PDA conducts the search for a permanent Editor. Richard V. Levy, PhD, retired as Editor-in-Chief of the PDA Journal of Pharmaceutical Science and Technology (JPST) after almost four years as its head. Gupta has been a member of the Journal Editorial Board since 2019 and, most recently, has served as an Associate Editor, helping evaluating and managing JPST submissions. He has been a PDA member for more than 30 years. 

Gupta has worked with the National Institutes of Health for almost 20 years, currently as a senior scientist in the Division of Cancer Prevention of the National Cancer Institute and consulting with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases. At NIH, he has been responsible for managing multiple translational projects designed to generate clinical product for use in Phase I and Phase 2 clinical trials. Gupta also collaborates with contract teams and actively participates in the design and development of formulations of several promising agents that have resulted in patent filings. He has supported over 40 IND submissions. 

Gupta holds a BS (Hons) in pharmacy from the University of Florida and a PhD in pharmaceutical chemistry from the University of Michigan, Ann Arbor. Prior to joining NIH, he was a project leader in sterile products development at Abbott Laboratories and filed the IND for the expanded use of a lung surfactant product (Survanta®), which was the first product of its kind for neonatal respiratory distress syndrome. Gupta has published more than 20 papers in various peer-reviewed journals and contributed to books. 

 

Associate Editors 

Tony Cundell, PhD, Microbiological Consulting, LLC

 

 

 

 

Editorial Board 

                                  James Akers, PhD, Consultant 

Jose Caraballo, MBA/ME, Kite, a Gilead Company

Dayue Chen, PhD, Genentech
                             
                                  H. Gregg Claycamp, PhD,  Independent Consultant 

Tony Cundell, PhD, Microbiological Consulting, LLC

Fenton Fong, Msc, xCellarate Technology Consulting Inc.

Shanker Gupta, PhD, U.S. National Institutes of Health

  Ankur Kulshrestha, PhD, Bristol Myers Squibb 

Kelvin Lee, PhD, NIIMBL

 Richard V. Levy, PhD, PDA (ret.)

Duncan Low, PhD, Claymore Biopharm LLC 

  Hanns-Christian Mahler, PhD, ten23 health AG

                               

                                   Neha Pardeshi, PhD, Amgen

 

     

                                  Wendy R. Saffell-Clemmer, MS, Baxter International Inc.

 

Tim Sandle, PhD, Bio Products Laboratory Limited


Alicja Sobantka , PhD, Octapharma
 


István Szikora, MBA/MS, Novartis
 
Edward C. Tidswell, PhD, Merck

Henrietta Vinnerås, MSc, Fresenius Kabi AB
Kelly Waldron, PhD, ValSource


Wesley Workman, PhD, Workman Biotech Consultants LLC

                                 

                                  Glenn Wright, PDA

Earl Zablackis, PhD, Sanofi Pasteur
 

Steve Zdravkovic, BS, Baxter International Inc.
 

Qingyu Zeng, PhD, West Pharmaceutical Services
 

                                 

                                 Daniele Zuccato, MS, SCHOTT AG 

 

PDA, Inc., Leadership 

Chair 

Susan Schniepp, Regulatory Compliance Associates Inc. 

Chair-elect 

Anil Sawant, PhD, Merck & Co., Inc./Merck Sharp & Dohme 

Treasurer 

Melissa Seymour, Biogen, Inc.

Secretary 

Emma Ramnarine, Roche Pharma 

Immediate Past Chair  

Jette Christensen, PhD, Novo Nordisk 

Directors 

Barbara Allen, PhD, Eli Lilly & Company 
Bettine Boltres, West PharmaceuticalServices
Tia Bush, Amgen, Inc.
Javier Camposano, Celltrion
Mirko Gabriele, Thermo Fisher Scientific
Ghada Haddad, PhD, Merck & Co., Inc./Merck Sharp & Dohme 
Andrew Hopkins, Abbvie
Stephan Krause, PhD, AstraZeneca Biologics
Amy McDaniel, Bristol Myers Squibb 
Mary Oates, PhD, Sanofi Pasteur
Mathias Romacker, (ret.)
Osamu Shirokizawa, Life Scienta Ltd.
 

PDA Staff Liaisons 

Richard Johnson, President & CEO 
Walter Morris, Sr. Director, Publishing & Press Relations